DocDollars

Blueprint Medicines Corporation

MA · United States · Reporting entity ID 100000756811

Total reported 2019–2025
$74.9M
#126 of 2,960 reporting companies — 0.1% of all reported industry payments
$9.72M in general payments across 29,350 records, plus $65.2M in research funding across 5,076 records.

How it breaks down

General payments $9,715,716
Research funding $65,207,757

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Blueprint Medicines Corporation reported $74.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #126 of 2,960 reporting companies. 87% of that was research funding and 13% general payments such as consulting, speaking, food and travel. 29,350 general payment records and 5,076 research records were filed.

Common questions about Blueprint Medicines Corporation

How much has Blueprint Medicines Corporation paid US doctors?

Blueprint Medicines Corporation reported $74,923,473 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $9,715,716 in general payments, $65,207,757 in research funding.

How does Blueprint Medicines Corporation rank among drug and device companies?

It ranks #126 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Blueprint Medicines Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.